UK markets close in 6 hours 38 minutes

Infinity Pharmaceuticals, Inc. (I3F.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.01710.0000 (0.00%)
As of 08:36AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,569
2,593
1,858
1,719
Cost of revenue
1,549
1,563
1,120
1,037
Gross profit
1,020
1,030
738
682
Operating expenses
Research development
27,076
32,411
31,647
26,761
Selling general and administrative
15,990
13,463
14,174
12,418
Total operating expenses
43,066
45,874
45,821
39,179
Operating income or loss
-42,046
-44,844
-45,083
-38,497
Interest expense
180
180
180
2,445
Total other income/expenses net
1,278
655
1
450
Income before tax
-40,948
-44,369
-45,262
-40,492
Income tax expense
-
-
-
0
Income from continuing operations
-40,948
-44,369
-45,262
-40,492
Net income
-40,948
-44,369
-45,262
-40,492
Net income available to common shareholders
-40,948
-44,369
-45,262
-40,492
Basic EPS
-
-0.50
-0.53
-0.68
Diluted EPS
-
-0.50
-0.53
-0.68
Basic average shares
-
89,248
85,597
59,858
Diluted average shares
-
89,248
85,597
59,858